Argenx will acquire Unnatural Products for up to $1.15 billion, merging its AI-driven macrocyclic peptide discovery with Argenx's immunology expertise. 🔗 Read the full story on GazeWire #Health #Biotech #Crispr #GazeWire
Private to this visit. Text and context are processed by AI.